BPGAM
XENT

BTG Pactual Global Asset Management’s Intersect ENT, Inc XENT Stock Holding History

BTG Pactual Global Asset Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-74,785
Closed -$2.1M – 183
2022
Q1 		$2.1M Buy
74,785
+63,026
+536% +$1.73M 0.28% 81
2021
Q4 		$321K Buy
+11,759
New +$319K 0.23% 33

BTG Pactual Global Asset Management's XENT Position: Q2 2022 in Review

BTG Pactual Global Asset Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 74,785 shares — an estimated $2.1M sold.

BTG Pactual Global Asset Management first reported a position in XENT in Q4 2021 and held it in 2 quarters. The position peaked at $2.1M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • BTG Pactual Global Asset Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 74,785 Intersect ENT, Inc shares in Q2 2022, an estimated $2.1M.
  • BTG Pactual Global Asset Management first reported a position in Intersect ENT, Inc in Q4 2021 and held it in 2 quarters.
  • BTG Pactual Global Asset Management's Intersect ENT, Inc position peaked at $2.1M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on BTG Pactual Global Asset Management's 13F filing for Q2 2022, filed 10 Aug 2022.